Thursday, September 28, 2023

Longtime Industry Expert Joins Preferred Medical

By ET Bureau - April 07, 2020 2 Mins Read

Preferred medical, industry expert

Preferred Medical, a leading pharmacy benefit manager and ancillary service partner in workers’ compensation, announced that Jim Andrews has joined the company as a chief clinical officer. 

Also Read: RPA Investment to Increase by 5% in the next 12 Months

Andrews has over 45 years’ experience in pharmacy administration, operations, and workers’ compensation. He brings a proven ability to solve challenging problems and communicate effectively through all verticals. 

In his role as a chief clinical officer, Andrews will guide and champion Preferred Medical’s team members and clinical partners in integrating and aligning care across the business to enhance clinical effectiveness. He will provide clinical strategy and program recommendations to drive value-based care to Preferred Medical’s customers.

“Everyone here at Preferred is thrilled to have Jim join our team,” said Amy Wrightsel, chief executive officer. “He is a thought leader in our industry and his vast experience in all phases of pharmacy and workers’ compensation will be key to our continued growth.”

Also Read: Dealing with Cybersecurity Fatigue?

Prior to joining Preferred Medical, Andrews held the positions of executive vice president of pharmacy services at Optum and general manager of clinical products and services at Healthcare Solutions, Inc. He is also a licensed Pharmacist in Georgia and Florida and affiliated with many professional associations within the industry.  

Check Out The New Enterprisetalk Podcast. For more such updates follow us on Google News Enterprisetalk News.


ET Bureau

The platform covers e entire enterprise technology space- including emerging technologies like RPA, AI, cloud, automation, and the entire gamut of digital transformation tools, strategies and management decisions.

Subscribe To Newsletter

*By clicking on the Submit button, you are agreeing with the Privacy Policy with Enterprise Talks.*